NCT01929629View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD0914

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Gonococcal (GC) Infection
Interventions
DRUG

Part A

Single ascending doses

DRUG

Part B

Single doses food effect. Subjects to receive 2 single doses, one in fed and one in fasted.

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY